Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stimulating Adipose Tissue Fatty Acid Disposal With Low-dose, Postprandial, Intermittent Niacin for the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD).

NCT06843148 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT06843148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06843148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stimulating Adipose Tissue Fatty Acid Disposal With Low-dose, Postprandial, Intermittent Niacin for the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD).
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Recruiting
Start date
June 22, 2026
Completion date
July 31, 2030
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis/nash, metabolic dysfunction-associated steatotic liver disease (masld), non-alcoholic steato-hepatitis (nash)